Sharing our perspective

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward.


  • Shipments of Opana® ER ended August 31

    by
    • Optum Workers' Comp
    | Sep 29, 2017
    Tag Icon
    FDA
    As a follow-up to the requested removal of Opana® ER from the marketplace by the FDA earlier this summer, Endo International plc confirmed they ceased manufacturing and shipping reformulated Opana ER (oxymorphone hydrochloride extended-release) on August 31, 2017. Endo expects pharmacies to carry stock and dispense this product through the end of 2017.


  • Medication recall for one lot of paroxetine 30 mg tablets from Zydus Pharmaceuticals

    by
    • Optum Workers' Comp
    | Sep 22, 2017
    Tag Icon
    Medication Recall
    Zydus Pharmaceuticals USA Inc, the United States division of Cadila Healthcare has voluntarily recalled 44,800 bottles of paroxetine 30 mg tablets from the US market. Zydus is recalling the medication due to the presence of foreign tablets, reported to be another medication (risperidone 0.25 mg tablets), found in the bottles.


  • Pharmacy Resource Guide now available

    by
    • Optum Workers' Comp
    | Sep 21, 2017
    Tag Icon
    Pharmacy Fee Schedules, Workers' Compensation
    We are pleased to share our 2017 Pharmacy Resource Guide. Inside you will find a state-by-state guide to the pharmacy fee schedule and jurisdictional maps highlighting key workers’ compensation laws and regulations.


  • Virginia finalizes regulatory activity to control opioid utilization

    by
    • Optum Workers' Comp
    | Sep 20, 2017
    Tag Icon
    PDMPs, Chronic Pain, Opioids
    The Virginia Board of Medicine and Board of Pharmacy recently implemented regulatory changes aimed at controlling opioid analgesic utilization through procedures for both prescribing and dispensing. The Board of Medicine amended a finalized emergency rule, similar to other states, putting in place prescribing controls on opioid analgesics utilized when treating acute pain. The emergency regulation also provides specific treatment protocols and requirements for chronic pain, including requirements to check the state PDMP program and complete a medical exam of the patient.






Subscribe

Stay informed by signing up to receive newsletters, alerts, insights and videos.
You can customize your content preferences after you subscribe.